首页|宫颈鳞癌组织中SCGB2A1表达及临床意义

宫颈鳞癌组织中SCGB2A1表达及临床意义

扫码查看
目的 探讨宫颈鳞癌中SCGB2A1 的表达及其临床意义.方法 对GEO数据库GSE39001 数据集进行差异基因表达分析.分析TIMER数据库中不同SCGB2A表达患者预后情况.收集 2015 年至 2017 年在湖南中医药高等专科学校附属第一医院进行手术治疗的 123 例宫颈鳞癌患者.其中 25 例癌组织和对应癌旁组织液氮冻存,行实时荧光定量 PCR(qPCR)检测SCGB2A1 基因表达.另外 98 例癌组织和癌旁组织石蜡包埋,免疫组化染色检测SCGB2A1 蛋白表达,比较其蛋白表达和临床病理特征的关系.采用Kaplan-Meier法绘制生存曲线分析,生存差异行Log-rank检验.Cox风险比例回归分析影响膀胱尿路上皮癌患者预后的因素.结果 GSE39001 数据集中SCGB2A1 是宫颈鳞癌差异表达基因,且表达下调.TIMER数据库发现SCGB2A1 低表达患者OS较SCGB2A1 高表达患者差(P<0.05).qPCR检测结果显示,癌组织中SCGB2A1 基因表达水平显著低于癌旁组织,差异具有统计学意义(P<0.05).免疫组化染色结果显示,癌组织中SCGB2A1 染色评分显著低于癌旁组织,差异具有统计学意义(P<0.05).SCGB2A1 表达与分化程度、TNM分期有关(P<0.05).SCGB2A1 低表达患者中位OS为 2.5 年,低于高表达患者的 3.6 年,差异具有统计学意义(P<0.01).单因素、多因素 Cox 风险比例回归模型分析,SCGB2A1 低表达是影响宫颈鳞癌患者OS的独立危险因素(P=0.013).结论 SCGB2A1 在宫颈鳞癌组织中低表达,且提示患者预后较差.
Expression and clinical significance of SCGB2A1 in cervical squamous cell carcinoma
Objective To investigate the expression and clinical significance of SCGB2A1 in cervical squamous cell carcinoma.Methods Differential gene expression was analyzed in GEO database GSE39001 dataset.The prognosis of patients with different SCGB2A expression in TIMER database was analyzed.A total of 123 patients with cervical squamous cell carcinoma underwent surgical treatment in the First Affiliated Hospital of Hunan College of Traditional Chinese Medicine from 2015 to 2017 were collected.The expression of SCGB2A1 gene was detected by real-time quantitative fluorescent PCR(qPCR)in 25 cancer tissues and adjacent tissues.In another 98 cases,SCGB2A1 protein expression was detected by paraffin embedding and immunohistochemical staining,and the relationship between protein expression and clinicopathological features was compared.Kaplan-Meier method was used to draw survival curve analysis,and survival difference was tested by Log-rank.Cox proportional regression analysis of risk factors affecting the prognosis of patients with bladder urothelial carcinoma.Results In GSE39001 data set,SCGB2A1 was differentially expressed in cervical squamous cell carcinoma,and its expression was down-regulated.The TIMER database found that patients with low expression of SCGB2A1 had worse OS than those with high expression of SCGB2A1(P<0.05).The result of qPCR showed that the expression level of SCGB2A1 gene in cancer tissues was significantly lower than that in adjacent tissues,and the difference was statistically significant(P<0.05).Immunohistochemical staining result showed that SCGB2A1 staining score in cancer tissues was significantly lower than that in adjacent tissues,with statistical significance(P<0.05).The expression of SCGB2A1 was correlated with the differentiation degree and TNM stage(P<0.05).The median OS was 2.5 years in patients with low SCGB2A1 expression,which was lower than 3.6 years in patients with high SCGB2A1 expression,and the difference was statistically significant(P<0.01).Univariate and multivariate Cox proportional regression analysis showed that low SCGB2A1 expression was an independent risk factor for OS in patients with cervical squamous cell carcinoma(P=0.013).Conclusion The expression of SCGB2A1 in cervical squamous cell carcinoma is low,and the prognosis of patients is poor.

Cervical squamous cell carcinomaSCGB2A1Biomarker

张艳、谢斯炜、范孝盈、罗喜

展开 >

412000 湖南株洲 湖南中医药高等专科学校附属第一医院妇科

宫颈鳞癌 SCGB2A1 生物学标志物

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(3)
  • 17